Alnylam executives are heralding the replication of data between approved medicine Onpattro and the investigational...

Yingli Pharma has tapped MD Anderson Cancer Center to support its U.S. expansion. The collaboration...

Kura Oncology is back in the game. Two months after the FDA sidelined its blood...

Researchers at Northwestern University developed a nanoparticle delivery system for a common immunosuppressant drug that...

Hongming Chen has ended her long affiliation with Kala Pharmaceuticals. Having been with Kala since...

Kenneth Galbraith has made an immediate mark on Zymeworks. Days after taking up the CEO...

Eli Lilly is so serious about becoming the leader in Alzheimer’s disease with donanemab that,...

At the end of Jay Bradner’s interview for Fierce JPM Week, the Novartis innovation chief...

Researchers at Cambridge and Bath universities in the UK, along with colleagues at the Ifakara...

Charles River Labs, an early-stage contract research organization, is diving deeper into artificial intelligence by...

Altos Labs just redefined big in biotech. Where to start? The $3 billion in investor...

Hal Barron, M.D., is leaving GlaxoSmithKline. After four years as chief scientific officer, Barron is...

Moon Surgical (formerly MastOR), is a medtech startup based in France. The company has developed...

Researchers at Yale University created a wearable air sampler clip that can be worn on...

Researchers at Linköping University in Sweden and Okayama University in Japan developed a shape-shifting microrobot...

Eli Lilly is busy making deals days after the J.P. Morgan Healthcare Conference wrapped. The...

Chamath Palihapitiya’s special purpose acquisition company is throwing its weight behind ProKidney. The merger will...

JLABS has grown into a massive organization that spans the globe and is helping big...

Ionis Pharmaceuticals-partnered tominersen looked to be down and out when Roche revealed the extent of...

Researchers at the University of Pennsylvania School of Medicine have created a new coating for...

The founder of Moderna’s incubator, Flagship Pioneering, penned his first annual letter charting the four driving...

Mithra has brushed off a missed co-primary endpoint in one of its two phase 3...

The European Medicines Agency (EMA) wants to speed up your clinical trials. Through the Accelerating...

Researchers at the University of Missouri-Columbia have developed a system to track hand use in...